Disease Overview：Achalasia（ACH）
Achalasia is a rare esophageal motility disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent peristalsis in the distal esophagus. This neuromuscular dysfunction—often linked to degeneration of inhibitory ganglion cells in the myenteric plexus—leads to progressive dysphagia, regurgitation, chest pain, and weight loss. Diagnosis relies on high-resolution manometry (HRM), barium swallow radiography, and upper gastrointestinal endoscopy to exclude malignancy or secondary causes. Without intervention, chronic stasis increases aspiration pneumonia and Barrett’s esophagus risk; long-standing cases may even elevate squamous cell carcinoma incidence. First-line therapies include pneumatic dilation and laparoscopic Heller myotomy—both aiming to disrupt the hypertensive LES while preserving anti-reflux mechanisms. Per-oral endoscopic myotomy (POEM) has emerged as a minimally invasive alternative with comparable efficacy and faster recovery.
China offers distinct advantages for achalasia management: leading digestive disease centers—such as Beijing Friendship Hospital and Shanghai Renji Hospital—boast extensive POEM and Heller myotomy experience, supported by state-of-the-art endoscopic platforms and real-time intraoperative manometry. Clinical outcomes align with international benchmarks: >90% symptom relief at one year, low perforation rates (<1%), and robust long-term follow-up data. Treatment costs are typically 40–60% lower than in the US or Western Europe, without compromising quality—driven by streamlined healthcare infrastructure and government-subsidized advanced procedures. As a dedicated medical tourism agency, we facilitate seamless access for international patients: coordinating appointments with certified gastroenterologists and thoracic surgeons, providing itemized, transparent pricing in advance, arranging visa support, accommodation, and post-procedure rehabilitation guidance—all tailored to individual clinical and logistical needs.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown for Achalasia (Gastrointestinal Medicine)
Non-Surgical / Conservative Management
*Target*: Mild symptoms, elderly/frail patients, or pre-procedural bridging.
- •Pharmacotherapy (nitrates, calcium channel blockers):
- *Cost*: ¥120–¥300/month ($17–$43) — includes generic isosorbide dinitrate or nifedipine ER
- •Botulinum Toxin Injection (Esophageal):
- *Procedure + Endoscopy*: ¥4,800–¥6,500 ($690–$935) - *Pre-op labs* (CBC, coagulation, LFTs, ECG): ¥320 ($46) - *Post-injection manometry (optional)*: ¥1,200 ($172)
Surgical / Procedural Interventions
*All procedures performed in GI endoscopy unit or thoracic surgery department.*
- •Pneumatic Dilation (PD):
- *Cost*: ¥8,200–¥11,500 ($1,180–$1,655) — includes fluoroscopic guidance, balloon kit, sedation - *Pre-op workup*: Esophagram (¥380), high-resolution manometry (HRM) (¥1,500), upper endoscopy (¥1,200) = ¥3,080 ($443)
- •Peroral Endoscopic Myotomy (POEM):
- *Cost*: ¥22,000–¥28,500 ($3,165–$4,100) — includes endoscope, submucosal dissection tools, OR time, anesthesia - *Pre-op workup*: HRM (¥1,500), endoscopic ultrasound (EUS) (¥1,800), CT chest/abdomen (¥1,400) = ¥4,700 ($676)
- •Heller Myotomy (Laparoscopic):
- *Cost*: ¥24,500–¥31,000 ($3,525–$4,460) — includes laparoscopic instruments, mesh (if needed), hospital stay (5 days) - *Pre-op workup*: Same as POEM = ¥4,700 ($676)
Special / Complex Condition Management
- •Refractory Achalasia (≥2 failed PD/POEM):
- *Repeat POEM*: ¥25,000–¥32,000 ($3,600–$4,600) - *Esophagectomy (Ivor Lewis)*: ¥68,000–¥89,000 ($9,780–$12,800), including ICU stay and reconstruction
- •Achalasia with Severe Megaesophagus (>7 cm diameter, food stasis):
- *Combined POEM + fundoplication*: ¥29,500–¥36,000 ($4,245–$5,180)
Quick Selection Guide
- •Age <50, no comorbidities, Eckardt ≥7: POEM — highest durable remission (85–92% at 5 years).
- •Age ≥75 or ASA IV: Botulinum toxin — lowest procedural risk; repeat every 6–12 months.
- •Budget-constrained (<$2,000 USD): Pneumatic dilation — cost-effective first-line with 70–80% 5-year success.
- •Failed dilation + BMI >35: Laparoscopic Heller — superior control of reflux vs. POEM in obesity.
- •Megaesophagus + aspiration pneumonia history: Esophagectomy referral — definitive but reserved for end-stage disease.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Achalasia Medical Vacation Packages
Curated transparent all-inclusive packages combining Achalasia treatment with China top medical destinations:
